COVIGRO: Impact of COVID-19 and the SARS-CoV-2 vaccine on placental and fetal development

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:0 publications

Grant number: 459222

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2021
  • Known Financial Commitments (USD)

    $211,488.24
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    Bujold Emmanuel, Boivin Guy
  • Research Location

    Canada
  • Lead Research Institution

    Université Laval
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Adverse events associated with immunization

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Pregnant women

  • Occupations of Interest

    Unspecified

Abstract

The scientific data on the impact of COVID-19 on pregnancy are limited but suggest an increase in complications such as preterm birth and preeclampsia. At the same time, the scientific data are limited regarding the effectiveness of the COVID-19 vaccine given during pregnancy and whether gestational age can influence its effectiveness and/or impact on the outcome of the pregnancy. We will compare two cohorts of pregnant women, one recruited before the pandemic (2017-2018) and one recruited during the 2020-2021 pandemic. Using blood tests collected at different times during pregnancy, and using questionnaires, we will be able to establish whether the patient was infected with COVID-19 and whether she received the vaccine. We will evaluate the effect of COVID-19 on placental development and fetal development, as well as on the rate of complications. Finally, we will evaluate whether the vaccine received during pregnancy is as effective as the vaccine received before or after pregnancy.